|
|
Volumn 303, Issue 16, 2010, Pages 1582-1584
|
|
Questionable antipsychotic prescribing remains common, despite serious risks
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARIPIPRAZOLE;
NEUROLEPTIC AGENT;
QUETIAPINE;
ALZHEIMER DISEASE;
DEMENTIA;
DRUG LABELING;
DRUG MARKETING;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MAJOR DEPRESSION;
MEDICAID;
MEDICAL SOCIETY;
PHYSICIAN;
POSTTRAUMATIC STRESS DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
PSYCHOSIS;
SCHIZOPHRENIA;
SHORT SURVEY;
UNITED STATES;
CLINICAL PRACTICE;
NOTE;
OFF LABEL DRUG USE;
PSYCHIATRY;
ANTIPSYCHOTIC AGENTS;
HUMANS;
OFF-LABEL USE;
PHYSICIAN'S PRACTICE PATTERNS;
PSYCHIATRY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 77951627681
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2010.453 Document Type: Short Survey |
|
Times cited : (25)
|
|
References (0)
|
